Filing Details
- Accession Number:
- 0001181431-14-026679
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2014-07-15 11:24:56
- Reporting Period:
- 2014-07-11
- Filing Date:
- 2014-07-15
- Accepted Time:
- 2014-07-15 11:24:56
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 819050 | Vical Inc | VICL | Biological Products, (No Disgnostic Substances) (2836) | 930948554 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1594935 | Russell Lawrence Smith | 10390 Pacific Center Court San Diego CA 92127 | Vp, Vaccine Research | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock $.01 Par Value | Disposition | 2014-07-11 | 1,912 | $1.16 | 191,301 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Sale of 1,912 shares of common stock issued upon release of 3,824 restricted stock units on July 7, 11 and 13, 2014 to cover withholding taxes, with the balance of the shares (1,912) maintained by the Reporting Person. The sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on February 25, 2014.
- Represents a weighted average sales price per share. The prices actually received ranged from $1.15 to $1.18. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
- This balance includes 134,730 unvested shares subject to restricted stock units.
Billionaire Hedge Funds
